West Pharmaceutical Services (WST)

Cost of Revenue

$543.10M

Quarterly · Period ending: · USD

WST logo

WST Cost of Revenue

Latest reported$543.10M
WST Quarterly Cost of Revenue ($0.00 → $543.10M)
High-resolution chart · PNG

WST cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

West Pharmaceutical Services Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
85,600,000
85,500,000
45,800,000
79,900,000
84,500,000
79,500,000
43,900,000
80,800,000
84,600,000
79,800,000
46,800,000
80,500,000
81,000,000
73,900,000
43,700,000
76,000,000
86,800,000
82,000,000
50,600,000
81,700,000
87,100,000
82,600,000
48,900,000
76,400,000
77,100,000
63,100,000
44,000,000
62,000,000
61,700,000
58,200,000
41,300,000
57,800,000
60,200,000
62,800,000
40,600,000
59,100,000
61,000,000
57,400,000
37,900,000
59,800,000
60,400,000
63,300,000
37,600,000
59,400,000
62,900,000
61,300,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.